Q: What do you think of METLIFE right now as a dividend paying long term conservative investment? Any recent changes in their prospects or long term concerns?
Thanks
Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi Team,
Read your assessment of EQIX and agree. Is there a recommended company in the data centre space ? COR ?
Read your assessment of EQIX and agree. Is there a recommended company in the data centre space ? COR ?
Q: Hi, what's your opinion on Gilead Sciences at these prices, is it a value trap or falling knife?
Thanks
Ken
Thanks
Ken
Q: What is your longer term view on Canadian Solar on the NY exchange
Q: Hello I5, I have US$ to invest and looking to select one or two of CSCO,HPQ, GLW T and PHG for income and some capital growth. I would appreciate, your suggestion, perhaps, can offer another one. Many thanks for your help.
J.A.P. Burlington
J.A.P. Burlington
Q: What is your opinion of vanguard ETF VXC ? Would you buy sell or hold?
Q: I would like your opinion of the following two companies. CRTO CriteoSA and MIND Mainstreet Capital. Your opinion of their investability, stability, growth, and all other criteria you deem important. Thank you.
Q: I am seriously considering adding Avery Dennison to my US portfolio.
Although not Canadian your comments would be appreciated
Dave
Although not Canadian your comments would be appreciated
Dave
Q: Ebix has been a company you've previously mentioned is a good US company to be involved with. Been a long time holder of the company and just wanted a "health" check up on the company and what you're opinion of the most recent quarter released earlier today.
Q: I was hoping to buy more NVDA, but it keeps going up!! Is it getting too expensive? Any other ideas of US upwardly mobile stocks in any sector?
Q: I realize that this is outside of your core coverage, but I'm wondering if you could provide an opinion on Cimpress on the Nasdaq?
Q: Hello Peter, Ryan & 5i Team
I'm looking to bulk up my US exposure, specifically US$ income rather than growth names. Would you favour ETFs or a small set of individual companies for this purpose (any suggestions of either? Thank you)
As always, thank you for your insights and wisdom.
I'm looking to bulk up my US exposure, specifically US$ income rather than growth names. Would you favour ETFs or a small set of individual companies for this purpose (any suggestions of either? Thank you)
As always, thank you for your insights and wisdom.
Q: What do you think of this company which is a supplier of powertrain systems to most car companies. It seems to be a very stable company with a decent moat.
The only 2 things I can see is the vehicle market is slowing and their dept more than doubled over the past year (I think they issued notes recently).
Thank You,
Andrew
The only 2 things I can see is the vehicle market is slowing and their dept more than doubled over the past year (I think they issued notes recently).
Thank You,
Andrew
Q: Hello 5i team
I was curious if you thought that the move on Bristol Myers was over done and that this may be a opportunity to buy in?
I was curious if you thought that the move on Bristol Myers was over done and that this may be a opportunity to buy in?
Q: I have noted that this company's stock has fallen lately. I would like your opinion
Q: I plan to take some new positions in the US part of my growth stock portfolio. I wonder if you can give me an opinion on Wayfair as a potential candidate. Do you have any other US growth names you could suggest?
Q: Stamp.com, NASDAQ:STMP
I appreciate your opinion on this company. It seems to me that it has good earning growth, and many analyst have strong buy recommendation but shares have not been doing well recently. If I sell this company at a loss would you recommend any similar company with a better risk reward prospect? Thanks
I appreciate your opinion on this company. It seems to me that it has good earning growth, and many analyst have strong buy recommendation but shares have not been doing well recently. If I sell this company at a loss would you recommend any similar company with a better risk reward prospect? Thanks
Q: I know you don't focus on US stocks but would appreciate your opinion on KR. What other companies within the same sector in the US that you like?
-
Brookfield Renewable Partners L.P. (BEP.UN)
-
Brookfield Property Partners L.P. (BPY.UN)
-
BMO Europe High Dividend Covered Call Hedged to CAD ETF (ZWE)
-
BMO US High Dividend Covered Call ETF (ZWH)
-
BMO US Put Write ETF (ZPW)
-
iShares S&P/TSX Capped REIT Index ETF (XRE)
Q: I currently hold BPY (up 50% over cost) and H&R in my portfolio 4% and 3% respectively.
I am considering swapping BPY for BEP for the additional income. Your thoughts?
I also plan to crystallize my capital losses and purchase the following ETFs:
Non registered:
ZPW – US Put Write
ZWE – Europe Covered Call hedged to CAD.
ZWH – US covered call
CPD – CAD preferred
XRE – Capped REIT
Registered (RRIF):
PGX:US – Preferred.
Each would constitute 2% - 3% of my portfolio. Diversification is my intention, but risk and surety of income is the primary consideration in all of the above noted.
Again, your thoughts.
Thank you for considering my questions
Gail
I am considering swapping BPY for BEP for the additional income. Your thoughts?
I also plan to crystallize my capital losses and purchase the following ETFs:
Non registered:
ZPW – US Put Write
ZWE – Europe Covered Call hedged to CAD.
ZWH – US covered call
CPD – CAD preferred
XRE – Capped REIT
Registered (RRIF):
PGX:US – Preferred.
Each would constitute 2% - 3% of my portfolio. Diversification is my intention, but risk and surety of income is the primary consideration in all of the above noted.
Again, your thoughts.
Thank you for considering my questions
Gail
Q: Can you please comment on Collegium Pharmaceutical (NASDAQ:COLL). I know you do not cover use stocks but I would appreciate any input you may have. The stock is down 50% ytd and reports earnings in the next 2 weeks.